Skip to Content

277 (Januvia 100 mg)

Generic Name: sitagliptin

Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 277

Januvia 100 mg 277
Januvia 100 mg 277  Front
Januvia 100 mg 277  Back
Januvia 100 mg 277  Front
Januvia 100 mg 277  Back
Januvia 100 mg 277

Januvia

Generic Name
sitagliptin
Imprint
277
Strength
100 mg
Color
Brown
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Merck & Company Inc.
Inactive Ingredients
calcium phosphate dibasic anhydrous, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00006-0277 Merck
54569-5925 A-S Medication Solutions, LLC (repackager)
54868-5840 Physicians Total Care Inc. (repackager)
35356-0103 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "277"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.